questionText: To ask the Secretary of State for Health and Social Care, in which patient groups will recommendations for combining GLP-1 receptor agonists with SGLT2 inhibitors be included as part of the updated NG28 guidelines.
answerText: The National Institute for Health and Care Excellence (NICE) develops its guidelines independently based on a thorough assessment of the available evidence and through extensive engagement with stakeholders.The NICE’s independent committee is currently up...
heading: Diabetes: Drugs